Gangrene Treatment Drugs Market Size

Gangrene Treatment Market size was over USD 1.67 billion in 2023 and is projected to cross USD 3.83 billion by the end of 2036, witnessing more than 6.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of gangrene treatment is estimated at USD 1.76 billion.

The growth of the gangrene treatment market can be attributed to factors such as the increasing prevalence of diabetes and its related complications, growing demand for sophisticated therapies and rising number of incidences of severe traumatic injuries. According to the World Health Organization (WHO), diabetes is a major cause of blindness, stroke and lower limb amputation. Along with these, growth in the total obese population worldwide is projected to offer ample opportunities to market growth in the coming years.